Cytokine production profile in patients with Behcet's disease treated with infliximab
Authors:
- Eri HagiwaraEHEri Hagiwara
- Mitsuhiro TakenoMTMitsuhiro Takeno
- Yukiko TakedaYTYukiko Takeda
- Yuko InoueYIYuko Inoue
- Takashi TsujiTTTakashi Tsuji
- Atsuhisa UedaAUAtsuhisa Ueda
- Satoshi NakamuraSNSatoshi Nakamura
- Shigeaki OhnoSOShigeaki Ohno
- Yoshiaki IshigatsuboYIYoshiaki Ishigatsubo
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Cytokine profile in Behçet's disease patientsScandinavian Journal of Rheumatology, 2002
- Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor α antibodyGut, 2001
- Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritisArthritis & Rheumatism, 2000
- Behçet's DiseaseNew England Journal of Medicine, 1999
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functionsCytokine, 1995
- Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.Journal of Clinical Investigation, 1994
- Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo.Journal of Clinical Investigation, 1994
- CD4+Lymphocyte Involvement in Ocular Behclet's DiseaseAutoimmunity, 1992
- Studies on Spontaneous Production of Gamma-Interferon in Behçet’s DiseaseOphthalmologica, 1982